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Abstract Structural gene expression of human immunodefi- 
ciency virus type 1 (HIV-1) requires a viral regulatory protein, 
Rev transactivator. We investigated Rev-dependency of HIV-1 
gene expression by various reporter systems. Expression of 
unspliced and singly-spliced viral mRNAs was demonstrated to 
be differentially dependent on the Rev function. This difference 
of Rev-dependency was found not to be determined by cis-ele- 
ments in gag, pol, and env coding sequences reported so far, and 
was lost when the reporter constructs containing minimum ele- 
ments for Rev-responsiveness uch as splice signals and rev re- 
sponsive element were used for experiments. These findings indi- 
cated that fundamental structure of HIV-I mRNA was critical 
for the differential regulation of gene expression by Rev transac- 
tivator. 
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1. Introduction 
Human immunodeficiency virus type 1 (HIV-1) is catego- 
rized under lentivirus by its complicated genome structure. Len- 
tivirus is distinct from oneovirus such as murine and avian 
leukemia viruses in its complex mechanism of gene expression 
[1-3]. Among various regulatory genes, rev gene is commonly 
found in almost all lentiviruses [4-11] and function of HIV-1 
Rev has been extensively studied [12-14]. Rev protein of HIV-1 
positively modulates virion production through up-regulation 
of mRNA transport into cytoplasm by interaction with its 
RNA target, Rev responsive element (RRE) [13,14]. It has been 
postulated that inhibitory sequences named cis-acting repres- 
sion sequence (CRS) [14,15], inhibitory sequence (INS) [16,17] 
and cis-acting inhibitory region (IR) [18] in coding regions of 
structural genes prevent ransport of mRNAs for these genes 
into cytoplasm, and Rev protein relieve this supression. The 
other assumption of Rev function is that splice signals present 
in HIV-1 genome confer Rev-dependency on some species of 
HIV-1 mRNAs [13,19 21]. 
HIV-I mRNAs are classified into three major groups by their 
size [22]. Full-length mRNA serves as viral genomic RNA and 
encodes gag and pol genes. Medium-size mRNAs (singly 
spliced) encode vif, vpr, vpu, and env genes. Small-size mRNAs 
(multiply spliced) encode tat, rev, and nef genes. It has been 
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reported that rev gene function was required for expression of 
full- and medium-length mRNAs, by which virus structural 
proteins were encoded [23,24]. In this report, we examined 
Rev-requirement of the three groups of mRNAs by various 
assay systems and found that expression of full- and medium- 
length mRNAs was differentially dependent on Rev function. 
Deletion analysis revealed that most of the cis-acting inhibitory 
sequences reported previously [14-18] did not contribute either 
to this difference and to Rev functionality. Our data strongly 
suggested that fundamental elements on mRNAs such as splice 
signals had crucial role for regulation of gene expression by Rev 
transactivator. 
2. Materials and methods 
2.1. Cell lines and DNA transfeetion 
A human colon carcinoma cell line, SW480 [25], a monkey kidney 
cell line, Cos-7 (ATCC CRL 1651), ahamster kidney cell line, BHK21 
(ATCC CCL 10), a murine cell line, SC-I [26], and a feline kidney cell 
line, CRFK (ATCC CCL 94), were maintained inDulbecco's modified 
Eagle medium supplemented with 10% heat-inactivated fetal calf 
serum. A CD4-positive human T-cell eukemic cell ine, A3.01 [25], and 
a CD4-positive human histiocytic lymphoma cell line, U937 (ATCC 
CRL 1593), were maintained inRPMI1640 medium supplemented with 
10% heat-inactivated fetal calf serum. For transfection of adherent 
(SW480, Cos-7, BHK21, SC-1, CRFK) and non-adherent (A3.01, 
U937) cells, calcium phosphate coprecipitation [27] and modified 
DEAE-dextran [28] methods were used, respectively. 
2.2. CA T assay 
The chloramphenicol acetyltransferase (CAT) assay has been previ- 
ously described [29]. CAT levels were assayed in equivalent amounts 
of cell lysates prepared from transfected cell lines. For quantitation, 
radioactivity ofspots corresponding to acetylated and non-acetylated 
forms of chloramphenicol on thin layer chromatograms was deter- 
mined by bio-imaging analyzer BAS2000 (Fuji Photo Film, Corp., 
Tokyo, Japan). Transfection with a plasmid pSVflGAL (Promega Co. 
Ltd, WI, USA) producing fl-galactosidase was used as a control for 
transfection efficiency. Comparable vels of bGAL were produced in 
each experiment. 
2.3. RT assay 
Virion-assoeiated r verse transcriptase (RT) activity was measured 
as described previously [30]. For quantitation, radioactivity ofspots on 
DE81 paper (Whatmann I ternational Ltd., Maidstone, England) was 
determined by bioimaging analyzer BAS2000. 
2.4. Preparation of cytoplasmic RNA and Northern blotting analysis 
Cytoplasmic RNA was prepared from transfected SW480 cells by 
NP40-disruption [31] and AGPC [32] methods. An equal amount of 
cytoplasmic RNA (5 pg) was electrophoresed through 1.2% agarose 
gels containing 2.2 M formamide, and analyzed by Northern blot hy- 
bridization [31]. As a DNA probe for Northern hybridization, a cut-out 
DNA fragment (about 0.5 kb long) containing virus long terminal 
repeat was labeled with 3zp by the random primer DNA labeling kit 
(Takara shuzo, Co., Ltd., Kyoto, Japan). 
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Fig. 1. Expression of cytoplasmic mRNAs regulated by Rev transactivator. (A) Major three species of HIV-1 mRNAs and the genes coded for by 
these mRNAs. Medium- and short-length mRNAs contain many hetelorogous pecies of mRNAs [22], but only major species are presented. 
(B) Cytoplasmic mRNAs of HIV-1 analyzed by Northern blot analysis. A Rev-defective proviral DNA clone, designated pNL-Ba [8] (10 ,ug), was 
transfected into SW480 cells with a Rev-expression plasmid (+), prev 1 [21] (20 pg), or with its backbone plasmid (-), pRVSV [21] (20 pg) and 2 days 
later, cytoplasmic RNA was prepared. An equal amount of RNA (5 pg) was used for Northern blot hybridization. The positions of three species 
of HIV-1 mRNAs and of rRNAs (28S and 18S) are indicated by brackets and arrowheads, respectively. 
2.5. DNA construction 
All CAT containing viral reporters are derived from an infectious 
DNA clone of HIV-1 designated pNL432 (GenBank Accession No. 
M19921)[25]. pNLgCAT is previously referred to as pNLgCAT-R1 [8]. 
pNLeCAT was constructed by insertion of a CAT-containing fragment 
(HindIII-Sau3AI fragment of pSV2cat) [29] into SspI(nt 6,153)- 
DraIII(nt 6,591) sites of pNL432 (Fig. 2). pNLgCATzl was constructed 
by a deletion of SpeI-Ball fragment(nt 1,507 to 4,551 of pNL432) from 
pNLgCAT, pNLeCATA was made by a deletion of DraIII-SspI frag- 
ment(nt 6,591 to 7,556 of pNL432) from pNLeCAT. These reporters 
all have a frame-shift mutation in rev gene, as was described for a Rev 
mutant proviral clone pNL-Ba [8]. Another eporter clone pNLnCAT 
was previously described [33]. pRSp-gCAT was constructed by cutting 
out BssHII-PflMI fragment (nt 711 to 5,297 of pNL432) from 
pNLgCATA and inserting this into an expression vector pRVSV [21] 
(Fig. 2). pRSp-eCAT is previously referred to as pRSpCAT-R1 [21]. A 
Rev expression plasmid, prevl, was described previously [21]. 
3. Results 
3.1. Rev-dependency of expression of HIV-1 mRNAs 
Three major species of HIV-1 mRNAs were readily recog- 
nized by Northern blotting analysis. To investigate dependency 
of their expression on Rev regulatory protein, we examined 
Rev-requirement for cytoplasmic accumulation of each species 
of viral mRNAs. A Rev mutant proviral DNA clone, desig- 
nated pNL-Ba [8], was transfected into SW480 cells in the 
presence or absence of a Rev expression plasmid, and expres- 
sion of HIV-1 mRNAs was monitored. As shown in Fig. 1, 
full-and medium-length mRNAs depended upon Rev co-ex- 
pression for their accumulation i  cytoplasm. However, the 
medium-size mRNAs appeared to be expressed to a small ex- 
tent in the absence of Rev. Table 1 shows quantitative data of 
the Northern analysis. Although the amount of the full-length 
mRNA in cytoplasm was almost negligible without Rev pro- 
tein, medium-length mRNAs were definitely present in cyto- 
plasm in the same condition. Enhancement of accumulation of
medium-length mRNAs by Rev transactivator was low relative 
to that of the full-length mRNA (Table 1). In contrast o these 
two mRNA species, expression of short-length mRNAs was 
essentially independent on Rev protein (Fig. 1 and Table 1). 
These results showed that expression of each HIV-1 mRNA 
species was differentially regulated by Rev transactivator. 
3.2. Differential regulation of HIV-1 gene expression by Rev 
transactivator in various cell lines 
Three reporter clones, designated pNLgCAT, pNLeCAT 
and pNLnCAT, were constructed to determine responsiveness 
of each mRNA species to Rev protein more easily and sensi- 
tively (Fig. 2). CAT activity produced in the cells transfected 
with pNLgCAT, pNLeCAT or pNLnCAT was expected to 
represent expression of full-, medium- and short-length 
mRNAs in cytoplasmic fraction, respectively. To ascertain 
whether these reporters show Rev-responsiveness similar to 
that of three mRNA species, each of reporters was transfected 
into SW480 cells with or without a Rev expression plasmid and 
enhancement of CAT activity by Rev was determined (Table 
2). The results obtained with these 3 reporters were almost 
parallel with those of cytoplasmic mRNA analysis in Fig. 1 and 
Table 1. Drastic enhancement of CAT production by Rev 
transactivator in cells transfected with pNLgCAT was in good 
Table 1 
Enhancement of cytoplasmic mRNA expression by Rev transactivator 
mRNA length Rev 
+ 
Full 1732 36 48 
Medium 2454 336 7.4 
Short 5128 5692 0.9 
Ratio (+/-) 
A Rev-expression vector prevl [21] (+), or its backbone vector pRVSV 
[21] (-), was contransfected with a Rev-defective proviral clone pNL- 
Ba [8], and 2 days later RNA was prepared as described in section 2. 
Northern blot hybridization was performed as shown in Fig. 1B and 
radioactivity of the bands corresponding to three major species of 
HIV-1 mRNAs was measured by bio-imaging analyzer BAS2000. Data 
are presented inPSL units of this system, which are proportional tocpm 
units. Results are presented as an average of three independent experi- 
ments. 
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Fig. 2. Structures of reporters to monitor Rev activity. Each reporter contains CAT gene as a marker gene. The genome structure of an infectious 
DNA clone of HIV-1, named pNL432 [25] and the recognition sites of restriction endonucleases used for DNA manipulations are shown at the top. 
Closed and open arrowheads indicate major donor and acceptor signals for mRNA splicing, respectively [22]. Sequences contained in the reporters 
(bold line) and the position of CAT gene inserted into the reporters are also indicated, rev gene of each pNL reporter is disrupted by a frame-shift 
mutation at the BamHI site [8]. RSV promoter and SV40 poly(A) signal are represented by open arrows and open boxes, respectively. 
agreement with that of virion production of Rev-deficient virus 
by Rev previously reported by us [8]. 
By using these reporter clones, we determined whether the 
differential regulation of HIV-1 gene expression by Rev is com- 
monly observed in various cell lines. Several cell lines derived 
from primates, rodents and feline were transfected with CAT- 
containing reporter clones in the presence or absence of Rev, 
and expression of CAT activity was examined. In all cell lines 
tested, generally similar results with those in SW480 cells were 
obtained (Table 2). There was no clear cell-specificity with 
respect o Rev-responsiveness. However, in cell lines U937 and 
SC-1, expression of CAT directed by pNLgCAT and pNLe- 
CAT was very poor even in the presence of Rev. Worthy of note 
is that CAT production by pNLnCAT was also very low in 
SC-1 cells. These results suggested that there was some cell- 
specific dependency of HIV-1 mRNA expression on Rev. 
3.3. Determinant for differential regulation by Rev 
transactivator 
To determine the location (gag-pol and/or vpu-env) of ele- 
ment(s) responsible for the differential regulation by Rev 
transactivator presented above, deletion analysis of CAT-con- 
taining reporters was performed. We constructed pNLgCATA 
and pNLeCATA, which have large deletions in gag-pol and env 
coding sequences, respectively (Fig. 2), and cotransfection ex- 
periments in SW480 cells were carried out using these reporters. 
As shown in Fig. 3, these deletions had no influence on the 
Rev-responsiveness of parental reporter clones. These results 
Table 2 
Transactivation of reporter CAT constructs by Rev protein in various cell lines 
CEll pNLgCAT pNLeCAT pNLnCAT 
+ - Ratio + - Ratio + - Ratio 
SW480 58.7 1.4 42 76.4 22.1 3.5 86.2 92.6 0.9 
COS7 43.4 0.5 87 24.9 3.0 8.3 35.4 64.5 0.5 
A3.01 34.3 0.5 69 71.7 14.5 4.9 74.2 88.1 0.8 
U937 0.7 * ** 4.4 0.6 7.3 23.4 54.5 0.4 
SC-1 0.5 * ** 1.1 0.5 2.2 8.0 5.8 1.4 
CRFK 43.7 0.7 62 71.4 12.0 5.9 81.7 86.5 0.9 
BHK 19.8 0.4 50 21.5 2.2 9.8 59.6 47.1 1.3 
CAT-containing viral reporters were transfected into various cell lines with a Rev-expression vector prevl [21] or its backbone plasmid pRVSV [21]. 
Two days after transfection, CAT activity in the transfected cells was monitored. Percent conversion of chloramphenicol to its acetylated forms 
in the presence (+) or absence (-) of Rev protein, and transactivation ratio by Rev (+/-) are presented. *Background level of conversion (< 0.3%); 
**ratio can not be determined because (-)-value is too low. 
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Fig. 3. Rev-responsiveness of various reporter constructs. Each of re- 
porter constructs (1 ,ug) was transfected into SW480 cells with a Rev- 
expression plasmid prevl (10/,tg) (+) or its backbone plasmid pRVSV 
(10/zg) (-). Two days after transfection, cell lysates were prepared and 
CAT activity was determined. Percent conversion of chloramphenicol 
to its acetylated forms is shown. Left and right panels represent results 
obtained by 0.5 h and 3 h reaction time for CAT assay, respectively. 
clearly indicated that almost all cis-elements located in gag-pol 
and env coding sequences did not serve as the determinants for 
differential regulation by Rev regulatory protein. Furthermore, 
RT production in culture supernatants of SW480 cells trans- 
fected with pNLeCAT or pNLeCATA was drastically enhanced 
by Rev transactivator in a similar manner (data not shown). 
For more detailed analysis of the determinants for Rev- 
responsiveness, we constructed simple reporters designated 
pRSp-gCAT and pRSp-eCAT (Fig. 2). Expression of marker 
CAT gene of these clones was driven by RSV promoter, and 
most of the gag-pol and env coding sequences of pNLgCATA 
and pNLeCATA were removed from the two constructs (Fig. 
2). We have previously demonstrated that the regions contain- 
ing splice signals of pRSp-eCAT had an important role for 
Rev-functionality [21]. pRSp-gCAT and pRSp-eCAT were 
constructed so as to retain the splice signals. These CAT-re- 
porters were transfected into SW480 cells with or without a Rev 
expression plasmid, and CAT production was monitored. As 
shown in Fig. 3, Rev-responsiveness of the two reporters till 
remained, but the extent of activation of the clones by Rev was 
similar. These results howed that structural difference between 
pNL and pRSp constructs was important for the differential 
regulation by Rev regulatory protein, but not for Rev-function- 
ality. 
4. D iscuss ion  
We reported here that expression of HIV-1 genes was differ- 
entially regulated by viral transactivator, Rev. This is the first 
report on comparative analysis of Rev-responsiveness of three 
species of HIV-1 mRNAs. As clearly shown in this report, 
expression of gag-pol gene and genomic RNA was highly de- 
pendent on rev gene function, but those genes encoded for by 
medium-length mRNAs showed relatively low dependency 
(Fig. 1, Fig. 3, Table 1 and Table 2). This phenomenon was 
generally observed in a wide variety of cell lines (Table 2). These 
results suggested that virion production of HIV-1, which is 
mainly determined by gag-pol gene expression, is strictly con- 
trolled by Rev and that env and other genes encoded for by 
medium-length mRNAs can be partially expressed without 
Rev. Whether viral proteins are actually translated from these 
medium-length mRNAs in the absence of Rev in HIV-1 replica- 
tion cycle needs to be determined. 
The determinant(s) for the difference between dependencies 
of expression of full- and medium-length mRNAs on Rev func- 
tion was studied by using various CAT constructs (Fig. 2). One 
possibility was that some c/s-elements in gag-pol and vpu-env 
coding sequences have a crucial inhibitory effect on accumula- 
tion of mRNA in cytoplasm, and that the difference of the 
effect resulted in the distinct Rev-responsiveness of mRNAs. 
This is unlikely from the results that pNLgCATA and pNLe- 
CATA had essentially the same Rev-responsiveness with the 
parental reporters, pNLgCAT and pNLeCAT (Fig. 3). Report- 
ers pNLgCATA and pNLeCATA had large deletions in gag-pol 
and vpu-env coding sequences, respectively, and almost all 
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Fig. 4. Cis-acting inhibitory sequences and reporter clones used in this study. The location ofcis-acting repression sequences designated as CRS [14,15], 
INS [16,17] and IR [18] are indicated. The sequences contained by some reporters used in this report are indicated by thick lines. The overlapping 
regions of reporters to cis-acting repression sequences are represented by bold dotted boxes. 
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presumed cis-elements [14-18] were removed (Fig. 4). Another 
possibility was that splice signals for removing out gag-po! and 
vpu-env sequences have different effects on accumulation of 
mRNAs in cytoplasm and confer distinct Rev-dependency on
mRNAs. To test this, we constructed two simple reporters, 
designated pRSp-gCAT and pRSp-eCAT (Fig. 2). These re- 
porters contained the splice signals for excluding exons ofgag- 
pol and vpu-env genes, respectively. These two reporters re- 
sponded in a similar way to Rev protein (Fig. 3). From these 
results, the splice signals present in pRSp-gCAT and pRSp- 
eCAT appeared not to contribute to differential response of 
mRNAs to Rev transactivator. Taken together, the differential 
regulation by Rev seemed to be determined not by cis-elements 
in gag-pol and vpu-env coding sequences, but by a fundamental 
viral structure remaining in both pNLgCATA and pNLeCATA. 
Deletion analysis described above also gives an insight into 
Rev action. It has been postulated that CRS [14,15], IR [16,17] 
and INS [18] prevent transport of full- and medium-length 
mRNAs into cytoplasm and that these elements confer Rev- 
dependency on these mRNAs. Although almost all of these 
elements were removed from our reporter clones pRSp-gCAT 
and pRSp-eCAT (Fig. 4), they still retained Rev-responsiveness 
(Fig. 3). Both pRSp reporters contained one of CRS's overlap- 
ping RRE [13,14], but we previously showed that a fragment 
containing RRE only was not sufficient o confer Rev-respon- 
siveness on mRNAs [21]. A portion of IR1, which carries the 
major splice donor, was contained in pRSp-gCAT. The IR1 
was reported to be an inhibitory region for gene expression but 
its significance for Rev functionality was unclear [18]. In addi- 
tion, a small part of the IRI had no apparent inhibitory effects 
on gene expression [18]. Thus, the possibility that this IRI 
fragment contributed to the Rev-responsiveness of pRSp- 
gCAT seemed to be unlikely. In contrast, our previous study 
on pRSp-eCAT [21] showed the importance of splice signals for 
Rev-functionality. On the basis of these results, it is likely that 
Rev-requirement for expression of mRNAs is conferred by 
splice signals rather than by cis-acting inhibitory sequences. 
It is worthy to note that full-length mRNA has more splice 
signals than medium-length mRNAs. Therefore, the former 
may show more dependency than the latter for its expression. 
Full-length mRNA of simple retroviruses such as murine leuke- 
mia virus has a structure similar to that of the medium-length 
mRNAs of HIV-1. These viruses can express whole sets of 
mRNAs without Rev-like function. 
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